Fortescue Ltd
FMG
Woodside Energy Group Ltd
WDS
Origin Energy Ltd
ORG
Telstra Group Ltd
TLS
BHP Group Ltd
BHP
Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 and PAT-DX1-NP, PAT-DX3 and PAT-LM1. Its lead technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody which penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.